Gene Query: PJA1

Dataset Description Geneva Score
mRNAseq of Huntington's disease and control patient iPSC-derived brain microvascular endothelial cells 63.75
mRNA sequencing of clinical-grade neural stem cells derived from human ES cells 23.26
Transcriptome variation among human embryonic stem cell lines impacts on their differentiation 22.1
Global transcriptional analysis and genome-wide analysis of chromatin state in extended pluripotent stem cells, primed pluripotent stem cells, and naïve pluripotent stem cells 19.1
Global transcriptional analysis of human extended pluripotent stem cells, human primed pluripotent stem cells, mouse extended pluripotent stem cells, and mouse embryonic stem cells by RNA-seq 19.1
Transcripotome analysis of different locations of hair follicles (bulb, bulge) in androgenetic alopecia 17.83
Human iPSC-based Modeling of Late-Onset Disease using Progerin-induced Aging 15.33
Novel Targeting of Transcription and Metabolism in Glioblastoma 14.67
The effect of engineered del(7q) on induced pluripotent stem cells (iPSCs) derived from patients with Shwachman Diamond Syndrome (SDS). 14.62
The effect of spontaneous acquisition of an extra chromosome 7 for engineered del(7q) on induced pluripotent stem cells (iPSCs) derived from patients with Shwachman Diamond Syndrome (SDS). 13.47
Isogenic patient-derived human iPSCs, wild-type or heterozygous for PIK3CA-E418K 12.61
Understanding the reproducibility and robustness of the kidney organoid differentiation protocol using RNA-seq 12.16
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [polyA RNA-seq] 12.12
Quantitative comparison between cellular mRNAs and exosomal mRNAs in human iPSC-derived motor neurons 12.09
Differential RNA-seq analysis comparing APC-defective and APC-restored SW480 colorectal cancer cells 11.64
Transcriptome-wide identification of CELF2 functional targets in T cells 11.45
PRRX2 and HEY2 double knock-down facilitates ASCL1-induced neuron conversion in human dermal fibroblasts. 10.45
JMJD3 and UTX Determine Fidelity and Lineage Specification of Human Neural Progenitor Cells [RNA-seq] 10.15
JMJD3 and UTX Determine Fidelity and Lineage Specification of Human Neural Progenitor Cells 10.15
Total RNA sequencing of APC mutant and wt colonic organoids 10.15
Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development 9.96
Adaptive chromatin remodeling in glioblastoma stem cell plasticity and drug tolerance 9.95
Induced pluripotent stem cell modeling of bone marrow failure and MDS identifies therapeutic targets 9.92
Human iPSC derived glomeruli facilitate accurate modelling of podocytopathy 9.8
Fisetin induces autophagy in pancreatic cancer cells via endoplasmic reticulum stress- and mitochondrial stress-dependent pathways 9.78
The E3 ubiquitin ligase HectD1 suppresses EMT and metastasis by targeting the +TIP protein ACF7 for degradation 9.67
mRNA expression data from ESCs derived by polar body transfer reconstructed embryos (PBTESCs) 9.41
Neonatal and adult human testis defined at the single-cell level 9.18
Epigenomic landscape during organ formation in human early embryos 9.0
Temporal activation of NR5A2 and RARγ induce functional human naïve pluripotent state via modulating TGFβ pathway 8.71
Gene expression profile in response to HIF-1α inhibition together with PPARα activation and the postnatal factors (T3, IGF-1 and dexamethasone) in hiPSC-CMs 8.61
Tracking of dCas9-methyltransferase footprints 8.14
Prospective Isolation and Comparison of Human Germinal Matrix and Glioblastoma EGFR+ Populations with Stem Cell Properties 8.12
Recapitulation of Human Neural Microenvironment Signatures in iPSC-Derived NPC 3D Differentiation 8.0
RNA-Seq profiling of days 0, 7 and 18 kidney organoids differentiated from three separate vials of starting material 7.94
RNAseq of HEK293 cells after Chtop knockdown 7.83
Co-transcriptional loading of RNA export factors shapes the human transcriptome 7.83
Transcriptome profiling of omental adipose tissues in human obesity by RNA-Seq 7.82
RNA-Seq from early time points in the kidney differentiation protocol 7.76
Human iPSC-derived glomeruli provide an advanced model to interrogate podocyte biology and accurately recapitulate podocytopathy 7.58
N6-methyladenosine Recruits HNRNPG for Alternative Splicing Regulation 7.37
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease (RNA-seq data set) 7.33
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease 7.33
Analysis of chromosomal aberrations and recombination by allelic bias in RNA-Seq 6.83
Verification and rectification of cell type-specific splicing of a Seckel syndrome-associated ATR mutation using iPS cell model 6.62
Identifying ASCL1 target genes in primary GBM stem cell cultures [RNA-seq] 6.59
Proteinase-Activated Receptor 4 (PAR4) mediates cell membrane blebbing in a Gaq/11, Gai independent, RhoA and ß-arrestin-dependent manner. 6.55
Enhancing human kidney organoid differentiation from pluripotent stem cells with high-throughput automation 6.44
Exploring transcriptomic landscapes in red cell populations, in their extracellular vesicles and on single cell level 6.43
Impact of ETV7 activity on interferon-stimulated gene expression in 293T cells treated with interferon alpha 6.4
ETV7 and interferon response 6.4
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation 6.27
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation (Human_RWPE1_RNA-Seq) 6.27
Transcriptional control of subtype switching ensures adaptation and growth of pancreatic cancer 6.25
GCTM-5 positive and negative cells in pancreatic adenocarcinoma cell lines 6.22
AMPK signaling for naïve pluripotency [Hs] 6.2
AMPK signaling for naïve pluripotency 6.2
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA-Seq] 6.16
Characterization of EZH2-deficient human embryonic stem cells [ChIP-seq and bulk RNA-seq] 6.13
RNA sequencing of BT142 and TS603 cell lines 5.96
Metabolic Reprogramming Associated with Aggressiveness Occurs in the G-CIMP-High Molecular Subtypes of IDH1mut Lower Grade Gliomas 5.96
Effect of REST on cancer invasiveness in MCF-7 and MDA-MB-231 cells using RNA-sequencing (RNA-seq) analysis . 5.92
Laminin-guided highly efficient endothelial commitment from human pluripotent stem cells [Bulk RNA-Seq] 5.91
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells [RNA-seq] 5.86
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells 5.86
Examining serotonergic neuron differentiation from human iPSCs 5.83
RNA-seq of tumor cells following angiopellosis extravasation 5.82
Transcriptomic analysis of human neural progenitor cells differentiation into astrocytes 5.76
Effect of the knockdown of MLL1 and MLL2 on pediatric high grade glioma 5.76
The identification of RBM47 binding sites and RBM47-dependent alternative splicing events in brain metastatic breast cancer cells 5.72
Identification of alternatively spliced transcripts in brain metastatic derivatives of MDA-MB-231 breast cancer cells in response to RBM47 expression 5.72
Rorc disruption in human FG pancreatic cancer cells 5.63
Gata6 potently initiates reprogramming of pluripotent and differentiated cells to extraembryonic endoderm stem cells 5.6
Gata6 potently initiates reprogramming of pluripotent and differentiated cells to extraembryonic endoderm stem cells [ChIP-Seq & RNA-Seq] 5.6
RNA-Seq of human PDA cell lines transfected with control siRNA or Pdx1 siRNA 5.59
RNA sequence of mRNA in HUVEC cells after depleting EGFL6 5.56
Biochemical fractionation of HEK293 nuclei and RNA-seq of chromatin-associated and soluble-nuclear RNA 5.44
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc [RNA-Seq] 5.44
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 5.44
RNA sequencing of hPSC-derived cardiac progenitors and endocardium 5.42
Transcriptome analysis of AGS cells infected with Helicobacter pylori P12 5.4
Induction of Sertoli-like cells from human fibroblasts by NR5A1 and GATA4 5.37
High-depth RNA sequencing of isogenic wild-type, PIK3CA-WT/H1047R and PIK3CA-H1047R/H1047R human iPSCs 5.36
Global gene expression profiles of cardiac progenitors differentiated from human pluripotent stem cells in 3D culture under simulated microgravity 5.34
Patient iPSC-derived neural stem cells display progressive enlargement of lysosomes and disruptions of glycosaminoglycan pathway and autophagy in concordance with clinical severity of Mucopolysaccharidosis I 5.31
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells (RNA-seq) 5.27
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells 5.27
Kidney organoid reproducibility across multiple human iPSC lines and diminished off target cells after transplantation revealed by single cell transcriptomics 5.25
Transcriptome of iPSC-derived Neural Cells with Heterozygous Knockout in CHD8 5.22
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 5.2
High-throughput sequencing of pluripotent cells 5.15
Patient-iPSC-derived kidney organoids show functional validation of a ciliopathic renal phenotype 5.13
Restoration of Progranulin Expression Rescues Cortical Neuron Generation in Induced Pluripotent Stem Cell Model of Frontotemporal Dementia 5.1
RNA-seq analysis of the human fetal kidney. 5.06
Characterization of sperm lncRNA and its differently expression in the sperm of asthenozoospermic patients 5.04
Locally transplanted human urine-induced nephron progenitor cells contribute to renal repair in mice kidney with diabetic nephropathy 4.99
scRNASeq analysis of cycling cardiomyocytes 4.96
m6A-seq data analysis of control and PCIF1 knockdown transcriptome 4.95
A SIRT1-centered Circuitry Regulates Breast Cancer Stemness and Metastasis 4.92
mRNAseq of Huntington's disease and control patient iPSC-derived neural cells 4.9
Transcriptomic and Epigenomic analysis of Huntington's disease and control patient iPSC-derived neural cells 4.9
Heterozygous and homozygous knock-in of PIK3CA-H1047R into human iPSCs 4.83
Activation of neuronal genes via LINE-1 elements upon global DNA demethylation in human neural progenitors 4.8
Role of miR-146a in neural stem cell differentiation and neural lineage determination: relevance for neurodevelopmental disorders 4.78
‘Naïve’ ESRRB+ iPSCs with the capacity for rapid neural differentiation 4.78
Oncogenic Serine-Threonine Kinase Receptor Associated Protein Supports Hepatocellular Carcinoma Cell Growth by Enhancing Wnt/β-catenin Signaling 4.68
Functional Comparison of the HGF/Met and MSP/Ron Systems in a Pancreatic Cancer Model 4.67
RNA-seq Profiles in Transcription elongation factors are in vivo-specific cancer dependencies in glioma 4.63
Transcription elongation factors are in vivo-specific cancer dependencies in glioma 4.63
Epigenome regulation during epidermal lineage commitment [RNA-seq] 4.62
Identification of Sin3B regulated genes during quiescence 4.6
Total RNA sequencing of WT intestinal orgaonids. 4.58
Effect of disulfiram treatment on pediatric high grade glioma 4.52
Cell cycle positioning drives heterogeneity within the pluripotent stem cell compartment 4.51
Directed differentiation of human embryonic stem cells to corneal endothelial cell-like cells: A transcriptomic analysis 4.49
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-Seq] 4.46
The metabolome regulates the epigenetic landscape during naïve to primed human embryonic stem cell transition 4.44
Single-cell analysis of adult human ovary using 10X genomics 4.43
A damaged genome's transcriptional landscape through multilayered expression profiling around in situ-mapped DNA double-strand breaks 4.42
RNA-seq of human iPS derived macrophages with or without KLF1- transcription factor Activation 4.4
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-seq] 4.4
Smad5 acts as an intracellular pH messenger and maintains bioenergetic homoeostasis 4.39
ONECUT2 Drives Neuroendocrine Prostate Cancer Through Hypoxia Signaling 4.37
SRSF1 role in cellular gene expression and splicing 4.37
A large panel of isogenic APP and PSEN1 mutant human iPSC neurons reveals shared endosomal abnormalities mediated by APP b-CTFs, not Ab [ribosome profiling] 4.35
TrapSeq: An RNA Sequencing-based pipeline for the identification of genetrap insertions in mammalian cells 4.35
Identification of mRNAs with reduced ribosomal loading upon knock-down of translation factor DAP5 from hESCs. 4.29
Proteomics identifies a marker signature of MAPKi resistance in melanoma 4.28
The impact of pro-inflammatory cytokines on the β-cell regulatory landscape provides insights into the genetics of type 1 diabetes 4.24
Identifying lincRNA as prognostic biomarker for clear cell renal cell carcinoma 4.23
RNA-sequencing (RNA-seq) in BxPC-3 and S2-007 cell lines 4.21
SHANK2 mutations associated with autism spectrum disorder cause hyperconnectivity of human neurons 4.2
Epigenome regulation during epidermal lineage commitment [ATAC-seq, RNA-seq] 4.18
Direct identification of endogenous SMG6 targets and a preferred motif spanning SMG6 cleavage sites by parallel analysis of RNA ends in human cells 4.17
Folliculin regulates mTORC1/2 and WNT pathways in early human pluripotency 4.16
Maturing an Enteric Nervous System in Human Intestinal Organoid-derived Tissue-Engineered Small Intestine 4.15
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma [RNA-seq] 4.14
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma 4.14
Modeling Trilateral Retinoblastoma using Human Embryonic Stem Cells 4.12
RNA-seq of naive and primed ES cells 4.12
HBEC-shp53-PCHD7 4.03
In vitro differentiation of human embryonic stem cells into ovarian follicle-like cells 4.0
Oncogenic MYC induces a dependency on the spliceosome in human cancer 3.99
Large-scale expansion of human iPSC-derived skeletal muscle cells for disease modeling and cell-based therapeutic strategies 3.97
Cranial pericytes derived from neural crest cells reveal an inherent cell type-specific defect in Alzheimer's Disease 3.94
Induction of human SST and PV neurons by expressing a single transcription factor LHX6 3.93
Analysis of MGE Transcriptomes with or without Ctnnb1 knockout in human through RNA Sequencing 3.93
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury [human iPS] 3.92
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury 3.92
RNA-sequencing of Wnt-dependent and Wnt-independent of Glioblastoma stem cell cultures 3.91
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 3.9
Patient Derived Xenograft for Delivery of Precision Medicine in Castrate Resistant Prostate Cancer 3.89
MBNL1-dependent modulation of gene expression in MDA-MB-231 breast cancer cells 3.85
Muscleblind-like 1 suppresses breast cancer metastatic colonization and stabilizes metastasis suppressor transcripts 3.85
RNA-Seq profiling of day 7 and day 18 kidney organoids differentiated in two batches 3.84
Total RNA sequencing of prospective axial stem cell cultures derived from human pluripotant stem cells 3.81
Heterozygous mutations in SMARCA2 lead to impaired neurogenesis due to global retargeting of SMARCA4 3.8
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [BAA] 3.78
Generation and persistence of human tissue-resident memory T cells in lung transplantation 3.78
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator 3.76
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator [RNA-seq] 3.76
Dynamics of Proteo-Transcriptomic Response to HIV-1 Infection 3.73
Identification of Atrial Fibrillation associated genes and functional non-coding variants 3.69
Discovery of cis-spliced chimeric RNAs between adjacent genes in human prostate cells 3.68
Parkinson’s Disease Genetic Risk in a Midbrain Neuronal Cell Line 3.68
Widespread N6-methyladenosine-dependent RNA Structural Switches Regulate RNA-Protein Interactions 3.66
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability 3.66
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability [RNA-Seq] 3.66
Differential expression of human parthenogenic stem cells, neural stem cells and DA progenitors. 3.64
PTEN suppresses neoplastic transformation of human neural stem cells by transcriptional repression of Pax7 3.63
Next Generation Sequencing Facilitates Quantitative Analysis of SW480 cells and HPSE-knockdown SW480 cells Transcriptomes 3.63
RNA-seq analysis of control and Myc-induced U2OS cells 3.61
Biased Expression of the FOXP3Δ3 Isoform in Aggressive Bladder Cancer Mediates Differentiation and Cisplatin Chemotherapy Resistance 3.6
Genome-wide analysis of YAP and TFCP2 down-regulated genes in liver cancer cells 3.59
Genome-wide analysis of YAP and TFCP2 occupancy and regulated expression in liver cancer cells 3.59
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [HCT RNA-Seq] 3.57
Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function 3.57
RNA-sequencing of isogenic primary, pre-malignant immortalized, and Ras-transformed human mammary epithelial cells 3.57
RNA-seq Profiles in RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 3.56
RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 3.56
A pooled single-cell genetic screen identifies regulatory barriers in the continuum of the epithelial-to-mesenchymal transition 3.55
Transcriptional analysis of ZIKV-infected Ifnar-/- and Ifnar+/- placentas and IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 3.55
Analysis of transcriptional differences after IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 3.55
Effects on gene expression of doxorubicin in human stem cells-derived cardiomyocytes 3.54
Next Generation Sequencing Compares Effects of microRNA-9 perturbation in control and SZ hiPSC NPCs 3.5
Transcriptome analysis of genetically matched human induced pluripotent stem cells disomic or trisomic for chromosome 21 3.5
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs 3.48
NSD2 overexpression links drives clustered chromatin and transcriptional changes in a subset of insulated domains of insulated domains 3.45
Modeling CADASIL vascular pathologies with patient-derived induced pluripotent stem cells 3.42
ATF4 inhibition by p62 represses stromal metabolic reprogramming and tumorigenesis II 3.42
Expression profiles of long non-coding RNAs located in autoimmune disease-associated regions reveal immune cell type specificity 3.39
m6A level and isoform characterization sequencing (m6A-LAIC-seq) reveal the census and complexity of the m6A epitranscriptome 3.33
Reduced CYFIP1 in human neural progenitors as 15q11.2 deletion model: donor specific dysregulation of schizophrenia/epilepsy genes 3.33
The regulartory role of ZCCHC24 in splicing machinery 3.33
Chromatin accessibility landscape upon induction of Msgn1, Pax3 and Myf5 in mesodermal cells and identification of conserved Pax3 binding sites and target genes during skeletal myogenesis 3.33
Silencing SPIB in attached and floating state of H1703 lung cancer cells 3.31
RNA-Seq analysis of neurons derived from induced pluripotent stem cells reprogrammed from dental pulp 3.3
iPSC-Derived Cholangiocytes 3.29
Proliferation-correlated expression 3.29
The Human Testis Cell Atlas via Single-cell RNA-seq 3.29
Over expression of Receptor Activity Modifying Protein 2 in HEK293T cells 3.28
Genome-scale screens identify JNK/JUN signaling as a barrier for pluripotency exit and endoderm differentiation 3.28
Effect of digoxin treatment on the gene and alternative splice expression in human pluripotent stem cells- derived mesenchymal stem cells 3.28
RNA-seq of SCLC PDX models treated with EP 3.27
Human pluripotent stem cell-derived brain tumor model uncovered embryonic stem cell signature as a key driver in atypical teratoid/rhabdoid tumor (RNA-Seq) 3.26
Transcription-dependent control of stem cell self-renewal and differentiation by the splicing factor U2AF1 3.26
mRNA expression data from human parthenogenetic haploid ESCs (hPGES), normal ESCs (H9) and human fibroblast 3.24
Genomic analysis of human parthenogenetic haploid ESCs (hPGES), normal human ESCs(H9) and human forskin fibroblast 3.24
Acquisition of a hybrid E/M state is essential for tumorigenicity of basal breast cancer cells 3.23
Stem and effector CD8 T-cells from human cancers 3.23
MARS Seq data from human cortical organoids 3.18
Genome-wide Analysis of Human Constitutive Androstane Receptor (CAR) Transcriptome in Wild-type and CAR-knockout HepaRG cells 3.17
RNA Seq analysis of NKX2-5 Null and Het human embryonic stem cells in cardiomyogenesis 3.17
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 3.14
iRNA-seq: Computational method for genome wide assessment of acute transcriptional regulation from total RNA-seq data 3.09
RNA sequencing analysis of selumetinib-resistant CRC cells lines 3.08
RNA-Seq characterization of human H1-derived NPC differentiation timecourse 3.05
Analysis of the Clustered Protocadherin (cPcdh) Locus in Human Pluripotent Stem and Derived Cells [RNA-seq II our of II] 3.05
RNA sequencing for PDX1, NGN3 and MAFA transduced iPSCs cell 3.03
Combined Experimental and System-Level Analyses Reveal the Complex Regulatory Network of miR-124 during Human Neurogenesis [ZNF787] 3.01
Antiviral innate immunity of hepatitis C virus-infected stem cell-derived hepatocytes 3.01
Global Mapping of Human RNA-RNA Interactions 3.0
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 2.98
Generation of low passage high grade serous ovarian cancer cell lines from primary tumors 2.97
Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21 2.94
Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21 [RNA-seq] 2.94
RNA-seq of naive and primed ES cells (NHSM) 2.94
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs 2.93
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs (expression) 2.93
Transcriptomes of iPSC-derived and post-mortum Hypothalamus Neurons from obese and control donors 2.92
RNAseq of IL-36 stimulated primary human keratinocytes 2.91
The cohesin release factor WAPL restricts chromatin loop extension. 2.91
The cohesin release factor WAPL restricts chromatin loop extension. [RNA-Seq] 2.91
RNAseq of Extracellular vesicle RNAs and cellular RNAs from HPASMCs with or without TGF-b1 or BMP4 treatment 2.9
Conserved roles for murine mDUX and human DUX4 in activating cleavage stage genes and MERVL/HERVL retrotransposons [RNA-Seq Human] 2.87
Characterization and therapeautic application of mesenchymal stem cells with neuromesodermal origin from human pluripotent stem cells 2.86
Gene expression in GBM with Cav3.2 inhibition 2.86
Sorted MDMs with RFP+GFP+ or RFP+GFP- Mtb 2.85
Nucleoporin-mediated regulation of cell identity genes 2.82
PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition 2.82
Gene expression in PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition. 2.82
Noncoding regions are the main source of targetable tumor-specific antigens 2.81
Network-based, cross-cohort discovery of transcriptional mechanisms presiding over maintenance of high-risk neuroblastoma subtype state 2.81
RNA-Seq of the corpus callosum from 12 individuals 2.8
Next Generation Sequencing Analysis of human embryonic stem cells derived MESP1-mTomato reporter cells 2.79
CD95L derived si- and shRNAs kill cancer cells through an RNAi mechanism by targeting survival genes [shL3.shR6.RNAseq.lg] 2.78
Gene expression profile in endometrial organoids cultured in normal follicular phase vs PCOS-like hormone profile 2.77
RNA isoform screens reveal the essentiality and tumor suppressor activity of ultraconserved poison exons 2.77
Gene expression and chromatin organization changes in lamin A/C haploinsufficient human induced pluripotent stem cell-derived cardiomyocytes [RNA-seq] 2.77
Gene expression and chromatin organization changes in lamin A/C haploinsufficient human induced pluripotent stem cell-derived cardiomyocytes 2.77
Transcriptomic analysis to functionally map the intrinsically disordered domain of EWS/FLI [Experiment 1] 2.75
RNA-Seq of cKIT+ sorted cells from 16-16.5 week old fetal testes and ovaries and RNA-Seq of TRA-1-60+ H1 hESCs 2.75
A bioinformatics approach reveals novel mechanisms of the OVOL transcription factors in the regulation of epithelial-mesenchymal cell programming and cancer progression. 2.74
Enhancement of Arterial Specification in Human Pluripotent Stem Cell Cultures Promotes Definitive Hematoendothelial Program with Broad Myelolymphoid Potential 2.71
Tissue-resident memory T cells mediate immune homeostasis in the human pancreas through the PD-1/PD-L1 pathway 2.71
Whole transcriptome profile of citrulline-specific B cells from patients with rheumatoid arthritis 2.69
Transcriptional regulation in pluripotent stem cells by Methyl CpG binding protein 2 (MeCP2) 2.65
Epigenome regulation during epidermal lineage commitment 2.65
Transcriptome analysis of H9 hESC derived cerebral organoids 2.65
PANCR, the PITX2 adjacent noncoding RNA, is specifically expressed in human left atria and regulates PITX2c expression 2.64
IMP3 regulated gene expression in breast cancer cells 2.63
Simultaneous quantification of antibody-RNA conjugates and the transcriptome from fixed cells by RAID 2.62
Next-generation sequencing of control and schizophrenia hiPSC derived NPC 2.62
Genome-wide transcriptome profiles in Control and Schizophrenia hiPSC-dervied NPC [RNA-seq] 2.62
Polycomb complexes associate with enhancers to promote oncogenic transcriptional programs in cancer 2.62
RNA sequencing of hiPSC derived neural crest populations from Familial Dysautonomia patients 2.62
Identifying markers predicting successful graft outcome for clinical translation of hESC-based cell therapy for Parkinson’s disease 2.6
The Human Testis Cell Atlas via Single-cell RNA-seq (Healthy men scRNA-seq data set) 2.58
RNA-Seq of LRRK2 G2019S Parkinson’s iPSC-derived astrocytes 2.58
ChIP-seq and RNA-seq analysis of KMT2D-silenced metastatic melanoma cells 2.56
Gene expression profile of LMSU gastric cancer cell p53 KO and KD 2.51
Real-time observation of light-controlled transcription in living cells 2.5
RNA-seq in transgenic cells 2.48
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process (RNA-seq) 2.47
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process 2.47
Gene expression profiling of papillary thyroid cancer from central and invasive regions 2.47
Assessing placental maturity through histological and transcriptomic analyses in idiopathic spontaneous preterm birth 2.45
HEK293 TFAM Knockout Expression Study 2.45
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes [RNA-Seq] 2.44
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes 2.44
Progressive motor neuron pathology and the role of astrocytes in a human stem cell model of VCP-related ALS 2.4
LncRNA DEANR1 facilitates human endoderm differentiation by activating FOXA2 expression 2.37
Ribosomal protein RPL26 is the principal target of UFMylation 2.36
Host transcriptome analysis of Aspergillus fumigatus infection in Airway Epithelial Cells 2.31
Expression profiling of pancreatic adenocarcinoma and ductal adenocarcinoma cell lines. 2.3
The Polycomb Repressor Complex 1 Drives Double-Negative Prostate Cancer Metastasis by Coordinating Stemness and Immune Suppression 2.29
LncPRESS1 is a p53-regulated lncRNA that safeguards pluripotency by disrupting SIRT6 mediated de-acetylation of histone H3K56 2.26
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells 2.25
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells (RNA-seq) 2.25
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition 2.25
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition [RNA-seq] 2.25
Highly-motile versus unsorted MDA-MB-231 breast cancer cells 2.24
Huntingtin aggregation impairs autophagy leading to Argonaute-2 accumulation and global microRNA dysregulation 2.19
LEDGF and HDGF2, histone H3K36 methyl-binding proteins that assist RNA polymerase II transcription through nucleosomes 2.19
P120-catenin dependent glioma-cell networks drive growth and diffuse brain infiltration 2.17
Serotonin-induced hyperactivity in SSRI-resistant major depressive disorder patient-derived neurons 2.17
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1, H1 derived APLNR+ cells, CD31+CD34+ cells and CD43+ cells during human early hematopoietic differentiation 2.15
RNAseq in Alzheimer's Disease patients 2.1
Perlman syndrome nuclease DIS3L2 controls cytoplasmic non-coding RNAs and provides surveillance pathway for maturing snRNAs 2.09
Transcriptome analysis of small molecule-mediated astrocyte-to-neuron reprogramming 2.08
Transcriptomic analysis of frontal fibrosing alopecia 2.07
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA_seq_Whole] 2.07
PolyA-sequencing in IMR-32 cells treated with THZ531 or DMSO 2.07
Heterogeneous effects of massive hypoxia pathway activation in kidney cancer 2.07
RNA-seq of SOX5 overexpressing primary human neuronal progenitors 2.06
Transcriptome profiling of self-renewing hESCs and multipotent mesoderm progenitor cells as a function of substrate stiffness 2.04
CLIC5: a novel ETV6 target gene in childhood acute lymphoblastic leukemia 2.02
SETBP1-WT and SETBP1-G870S transcriptional profiles [RNA-Seq] 2.02
SETBP1-WT and SETBP1-G870S epigenetic landscapes 2.02
Large-Scale Atlas of Mutant IDH1-Dependent Chromatin State Reprogramming, Reversibility, and Persistence 2.0
Large-Scale Atlas of Mutant IDH1-Dependent Chromatin State Reprogramming, Reversibility, and Persistence [RNA-seq] 2.0
Next-generation RNA sequencing to determine changes in gene expression during breast cancer progression 1.99
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies [RNA-seq data set 2] 1.97
Epigenetic silencing of the tumor suppressor RASSF4 favors multiple myeloma progression 1.94
Growth factor-free, chemically-defined culture system for expansion and derivation of human pluripotent stem cells 1.91
Human embryonic stem cells in E8 and AKIT culture medium 1.91
Derivation of ventrical and atrial cardiomyocytes and maturation using biowires 1.89
mRNA profiling reveals determinants of trastuzumab efficiency in HER2-positive breast cancer 1.86
Global transcriptome analysis of WT versus HEB-/- hESCs 1.84
Expression profiles of the four human major ectodermal lineages 1.84
Gene expression profile of human placenta from T. Cruzi infected mothers 1.83
LMO1 Synergizes with MYCN to Promotes Neuroblastoma Initiation and Metastasis 1.82
Allergen-specific immunotherapy modulates the balance of circulating Tfh and Tfr cells 1.8
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 1.76
Human Sandhoff Disease Cerebral Organoids Exhibit Enlarged Size, Increased Cellular Proliferation, and Impaired Differentiation 1.75
Genome wide transcript and miRNAanalysis of invitro and in-vivo generated human cardiac samples 1.73
Human interleukin-4 treated regulatory macrophages promote epithelial wound healing and reduce colitis in an mouse model 1.71
H3.3K27M cooperates with p53 loss and Pdgfra gain in mouse embryonic neural progenitor cells to induce invasive high-grade gliomas [Human RNA-Seq] 1.68
H3.3K27M cooperates with p53 loss and Pdgfra gain in mouse embryonic neural progenitor cells to induce invasive high-grade gliomas 1.68
CDK12 mediated transcriptional regulation in U2OS cells 1.67
Long non-coding RNA TYKRIL controls pericyte function and survival in the cardiovascular and central nervous system through regulation of p53 activity and PDGFRß expression 1.66
RNA-Seq of cKIT+ sorted cells from 53-137 day old fetal testes and ovaries and RNA-Seq of TRA-1-81+ H1 and UCLA1 hESCs. 1.64
cKIT+ sorted cells from 57-137 day old fetal testes and ovaries 1.64
1.64
Hypoxic transcriptome of SQ20B human head and neck cancer cells 1.64
FOXP1 orchestration of ASD-relevant signaling pathways. 1.61
Expression profiles of cultured human epididymis cells reveal the functional diversity of caput, corpus and cauda regions. 1.6
Single Cell Analysis Reveals Unexpected Transcriptional Heterogeneity of Neural Progenitors in the Developing Human Cortex 1.59
Transcriptome analysis of diverse cell types infected with human cytomegalovirus [RNA-Seq] 1.57
POLR3G Dependent PolyA+ and smallRNA Transcriptomes in Human Pluripotent Stem Cells 1.54
Molecular Criteria for Defining the Naive Human Pluripotent State 1.54
Enhancement of Human B Cell Differentiation and Function in Lymph Nodes by the TLR9 Agonist MGN1703 1.5
Differential responses of human fetal brain neural stem cells to Zika virus infection 1.48
Allogeneic mature human dendritic cells generate superior alloreactive regulatory T cells in the presence of IL-15 1.48
SILAC identifies LAD1 as an oncogenic filamin binder regulating actin dynamics in response to EGF and marking aggressive breast tumors 1.46
Role of FGFR1 in neuronal devlopment 1.46
RNA-seq of hiPSCs-derived NPCs from 3 pairs of dizygotic discordant twins for Congenital Zika syndrome 1.45
Rescue of Fragile X syndrome neurons by DNA methylation editing of the FMR1 gene [RNA-seq] 1.45
Rescue of Fragile X syndrome by DNA methylation editing of the FMR1 1.45
HLA peptides derived from tumor antigens induced by inhibition of DNA methylation for development of drug-facilitated immunotherapy 1.43
Analysis of human ES cell differentiation establishes that the dominant isoforms of the lncRNAs RMST and FIRRE are circular 1.42
FGF2 regulation of gene expression in stable inducible Neurons 1.41
Dissecting neural differentiation regulatory networks through epigenetic footprinting 1.41
Impact of DNA demethylation agents (5-azacytidine or vitamin C) on gene expression in glioblastoma HSR-GBM1 cells 1.33
Induced DNA demethylation, genome instability and transcription 1.33
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency (RNA-Seq) 1.32
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency 1.32
Genome-wide expression analysis of human hTert immortalized fibroblasts after donwregulation of MCM7 1.31
The transcriptome and chromatin accessbility landscape of mammalian germline 1.3
Zoledronic acid inhibits NFAT and IL-2 signaling pathways in regulatory T cells and diminishes their suppressive function in patients with metastatic cancer 1.3
Induction of extracellular adenosine salvage and metabolic quiescence regulate the transitional to follicular B cell checkpoint in humans. 1.29
Discovering human diabetes-risk gene function with genetics and physiological assays 1.28
Transcriptional response to the HSP70 inhibitor MAL3-101 in parental rhabdomyosarcoma cells and isogenic acquired-resistance lines. 1.26
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma 1.25
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma [RNA-seq] 1.25
Single-Cell Transcriptome Analysis of Lineage Diversity and Microenvironment in High-Grade Glioma 1.24
KSDM1b Role in Ewing Sarcoma 1.23
Regulating Interleukin-2 activity with engineered receptor signaling clamps 1.23
Next Generation Sequencing Facilitates Comparisons of Control and Schizophrenia-Patient derived hiPSC-derived neurons 1.2
Cystathionine-β-Synthase Promotes Colon Carcinogenesis 1.2
PT2385 HIF2A inhibitor treatment of patient derived orthotopic xenograft neuroblastoma cells in the presence or absence of hypoxia 1.18
Single cell transcriptomics analysis of induced pluripotent stem cell-derived cortical neurons reveals frequent dual layer identity 1.15
Zika virus directly infects human peripheral neurons and induces cell death 1.15
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 1.13
Metabolism as an early predictor of DPSCs aging 1.11
Human naïve pluripotent stem cells exhibit X chromosome dampening and X-inactivation (RNA-Seq) 1.11
Whole transcriptome sequencing of the human thyroid primary cells with knock-down of the NRG1 gene 1.1
Next Generation Sequencing Study of Circadian Changes in Transcriptome of Human Pineal Gland 1.09
Generating Patterned Kidney Organoids for Studying Development and Diseases [bulk RNA-Seq] 1.08
Single-cell RNA Sequencing Resolves Spatiotemporal Development of Pre-thymic Lymphoid Progenitors and Thymus Organogenesis in Human Embryos 1.08
Engineering Patient-Specific Tissue Implants 1.06
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 1.06
Robust generation of honemogeneous midbrain organoids with in vivo–like cellular composition facilitates neurotoxin-based Parkinson’s disease modeling 1.05
High-throughput RNAi cell viability screen to identify selective targets for EWS-FLI1 positive Ewing sarcoma 1.01
Reversing Abnormal Neural Development by Inhibiting OLIG2 in Down Syndrome Human iPSC Brain Organoids and Neuronal Mouse Chimeras 1.0
Transcriptome analysis reveals determinant stages controlling human embryonic stem cell commitment to neuronal cells 0.97
Evaluation of RNA amplification and RNA-Seq library preparation protocols for spermatozoa RNA profiling 0.96
Transcriptome profiling of H1-iCas9 cells grown on laminin and on MEFs 0.95
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HOM] 0.93
The circadian transcriptional landscape in primary human mammary epithelial cells 0.93
Single-cell analysis of human kidney organoids 0.92
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes 0.91
C19ORF66 broadly escapes viral-induced endonuclease cleavage and restricts Kaposi’s Sarcoma Associated Herpesvirus (KSHV) 0.9
Disease modelling of core pre-mRNA splicing factor haploinsufficiency 0.87
p53 activity results in DNA replication fork processivity 0.87
Identification of novel recurrent ETV6-IGH fusions in primary central nervous system lymphoma using high throughput RNA sequencing 0.86
UTX and 53BP1 co-regulate genetic programs for neural differentiation of human embryonic stem cells [RNA-seq] 0.85
UTX and 53BP1 co-regulate genetic programs for neural differentiation of human embryonic stem cells 0.85
Cajal bodies are linked to genome conformation [RNA-Seq] 0.85
Cajal bodies are linked to genome conformation 0.85
RNA-seq analysis of gene expression patterns during hESC neural differentiation 0.84
hESC neural differentiation 0.84
Transcriptome data of temporal and cingulate cortex in the Rett syndrome brain 0.81
RNA-Seq Analysis in hES/ iPS cell-derived neuronal samples 0.79
Derivation and differentiation of haploid human embryonic stem cells 0.78
Single amino acid change underlies distinct roles of H2A.Z subtypes in human syndrome 0.78
Prolyl hydroxylation regulates protein degradation, synthesis, and splicing in human induced pluripotent stem cell-derived cardiomyocytes 0.77
Microenvironmental-derived Regulation of HIF-Signaling Drives Transcriptional Heterogeneity in Glioblastoma Multiforme 0.76
Sex-specific gene expression differences are evident in human embryonic stem cells and during in vitro differentiation of human placental progenitor cells 0.76
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 0.75
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies 0.71
Enhancer divergence and cis-regulatory evolution in the human and chimpanzee neural crest 0.7
Genome-wide effect of inhibition of glutamine transporter ASCT2 in PC-3 cells by BenSer or GPNA 0.7
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 0.7
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 0.7
Analysis of gene expression, motif and pattern of m6A modified region and m6A enrichment level in Ocular melanoma and Melanocyte cell lines. Gene expressin analysis of METTL3 knock down in PIG1, ALKBH5 knock down and HINT2 over expression in OCM1. 0.7
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 0.7
Transcriptome Analysis Reveals Distinct Responses to Physiologic versus Toxic Manganese Exposure in Human Neuroblastoma Cells 0.68
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq Cell lines] 0.68
Human Embryoid Body Transcriptomes Reveal Maturation Differences Influenced by Size and Formation in Custom Microarrays 0.67
Epigenomic plasticity enables human pancreatic alpha to beta cell reprogramming 0.67
Transcriptome of iPSC-derived Cerebral Organoids with Heterozygous Knockout in CHD8 0.65
Transcriptomic analysis of human iPS cells derived from fragile X syndrome patients during neural differentiation 0.65
In vivo generation of post-infarct human cardiac muscle by laminin-promoted cardiovascular progenitors [LN-521 or LN-521+LN-221] 0.61
RNA-Seq Analysis in purified iPS cell-derived neuronal samples 0.61
Epigenetic activation and memory at a TGFB2 enhancer in systemic sclerosis 0.6
Transcriptome sequencing analysis of BRAF-mutant melanoma metastases. 0.58
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma (RNA-Seq) 0.57
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma 0.57
SQSTM1/p62-directed metabolic reprogramming is essential for normal neurodifferentiation 0.57
Gene expressions of H9s in different culture systems 0.56
Self-associated molecular patterns mediate cancer immune evasion by engagement of Siglec receptors 0.56
Transcriptome analysis of total RNA in human osteosarcoma cell line U2OS before and after inhibition of zinc finger protein ZNF768 0.54
Transcriptome Profiling Reveals the key genes and pathways involved in polycystic ovary syndrome [RNA-seq] 0.54
Identification of epigenetic interactions between miRNA and DNA methylation associated with polycystic ovarian syndrome 0.54
Reconstitution of the human pancreatic niche stimulates differentiation of hESCs into beta cells and reveals new signals for pancreatic endocrine cell maturation 0.53
CNOT1 and Transcriptomic Landscape of a HeLa Cell Line 0.53
Transcriptome analysis of diverse cell types infected with human cytomegalovirus 0.52
Comparative analysis of WT and ZEB1 KO cells in different stages during differentiation 0.52
The bromodomain protein BRD4 regulates splicing during heat shock 0.51
Evaluation of the effectiveness of semen collection and sperm purification methods for spermatozoa transcript profiling 0.5
Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas 0.49
Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas [RNA-seq] 0.49
Primate-specific gene TMEM14B promotes cortical expansion and folding 0.47
Low H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 0.46
Human HAP1 cells before and after nutrient deprivation 0.46
Transcriptomic profiling of human HAP1 cells before and after nutrient deprivation 0.46
RNA-Seq in PWS iPSC-derived neurons 0.46
Tissue-specific RNA-seq in human evoked inflammation identifies novel blood and adipose lincRNA signatures of cardio-metabolic diseases 0.46
RNA-Seq and expression data from human adipose tissue 0.46
FMR1 reactivating treatments in Fragile X iPSC-derived neural progenitors in-vitro and in-vivo 0.45
Transcriptome analysis of V336Y mutant mitochondrial ribosomal protein in human HEK293 cell line 0.44
Function and hormonal regulation of GATA3 in human first trimester placentation 0.41
An optimization system for isolating and sequencing of single human colon cancer cells 0.41
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 0.4
Glucose inhibits cardiac maturation through nucleotide biosynthesis 0.39
High-resolution comparative analysis of great ape genomes 0.39
Expression profiling of converted and control dermal BJ fibroblasts 0.38
p63 establishes epithelial enhancers de novo at critical craniofacial development genes 0.38
RNA-seq and small RNA-seq from WT and ADAR1 knockdown H9 lines and their differentiation to specific types of neurons 0.37
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis [RNA-Seq_Hs] 0.36
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis 0.36
Activin/Smad2-induced H3K27me3 reduction is crucial to initiate mesendoderm differentiation of ES Cells 0.35
Heterogeneous maintenance of human tissue resident memory T cells based on efflux capacities 0.33
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP [Ago2-miRNA-target mRNA complexes] 0.3
Genome-wide hsa-miR-503, hsa-miR-103, and hsa-miR-494 target profiles 0.3
hsa-miR-503, hsa-miR-103, and hsa-miR-494 genome wide target profiles [RNA-Seq and RIP-Seq] 0.3
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP 0.29
Human germ cell formation in xenotransplants of induced pluripotent stem cells carrying X chromosome aneuploidies 0.28
Human optic chiasm from healthy controls and multiple sclerosis patients 0.27
Multiple sclerosis and EAE 0.27
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 0.27
Trans-differentiation of human adult peripheral blood T cells into neurons 0.26
Integrated Multi-omic Analysis of Esthesioneuroblastomas Identifies Two Subgroups Linked to Cell Ontogeny 0.21
Derivation and differentiation of haploid human embryonic stem cells [RNA-Seq 1] 0.2
Deep RNA sequencing of the human placental transcriptome 0.18
Time series total RNA sequencing of a differentiation of human embryonic stem cells towards trophoblast lineage 0.17
Three congruent human Schwann cell models of CMT1A reveal a converged phenotype 0.17
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.16
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.16
PolyA-sequencing in IMR-32 neuroblastoma cells with shRNA mediated depletion of CDK12, CDK13 or GFP. 0.16
RNA sequencing from FOXM1 knockout HEK293T cells reconstituted with FOXM1 isoforms a, b and c. 0.15
Pancreatic Beta Cell Enhancers Regulate Rhythmic Transcription of Exocyst Triggering and Diabetes 0.15
Genome-wide Circadian Control of Transcription at Active Enhancers Regulates Insulin Secretion and Diabetes Risk 0.15
Co-regulation of splicing by Rbfox1 and hnRNP M 0.14
Co-regulation of splicing by Rbfox1 and hnRNP M [hnRNPM k-d+Rbfox1 RNA-Seq] 0.14
ALS implicated protein TDP-43 sustains levels of STMN2 a mediator of motor neuron growth and repair 0.14
Dissecting the single-cell transcriptome network underlying gastric premalignant lesions and early gastric cancer [10x genomics] 0.14
Evaluating and comparing the Transcriptome of (human) Hek 293 based cells, expressing either CHD3 or CHD4 0.12
Apoptosis enhancing drugs overcome innate platinum resistance in CA125 negative tumor initiating populations of high grade serous ovarian cancer 0.08
An intramolecular salt bridge linking TDP43’s RNA recognition motifs dictates RNA binding, protein stability and TDP43-dependent neurodegeneration 0.07
Pseudouridylation of tRNA-derived fragments steers translation control in stem cells [Polysome-Seq] 0.07
Transcriptional profiling of JEG3 cells with HLA-G ablation via deletion of Enhancer L 0.06
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 0.04
Human ovarian granulosa cell transcriptome 0.04
RUVBL1/RUVBL2 ATPase Activity Drives PAQosome Maturation, DNA Replication and Radioresistance in Lung Cancer 0.03
Comparison of 7 small cell lung cancer PDX models, cultured ex vivo, for response to LSD1 inhibitor RG6016/ORY1001 0.03
Folate modulation induces chromosomal instability and higher proliferation of immortalized human keratinocytes 0.02
Effects of Spaceflight on Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Structure and Function 0.01
CD133hi, Notchhi, DP (double positive) and DN (double negative) in GBML8 and GBML20, both patient-derived glioblastoma tumorsphere cultures 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation